These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 18991803)

  • 21. New antibiotics: optimal use in current clinical practice.
    Karageorgopoulos DE; Falagas ME
    Int J Antimicrob Agents; 2009; 34 Suppl 4():S55-62. PubMed ID: 19931821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapy of systemic fungal infections: a pharmacologic perspective.
    Wiebe V; Karriker M
    Clin Tech Small Anim Pract; 2005 Nov; 20(4):250-7. PubMed ID: 16317915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interactions between tacrolimus and antimicrobial agents.
    Paterson DL; Singh N
    Clin Infect Dis; 1997 Dec; 25(6):1430-40. PubMed ID: 9431391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [New systemic antifungal drugs: mechanisms of action, drug interactions and side effects].
    Schäfer-Korting M
    Mycoses; 2003; 46 Suppl 1():28-31. PubMed ID: 12955850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hybrid combinations containing natural products and antimicrobial drugs that interfere with bacterial and fungal biofilms.
    Zacchino SA; Butassi E; Cordisco E; Svetaz LA
    Phytomedicine; 2017 Dec; 37():14-26. PubMed ID: 29174600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Caspofungin acetate for treatment of invasive fungal infections.
    Pacetti SA; Gelone SP
    Ann Pharmacother; 2003 Jan; 37(1):90-8. PubMed ID: 12503942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug therapy of fungal and parasitic diseases.
    Weber LA; Tomecki KJ
    Dermatol Clin; 1989 Apr; 7(2):387-96. PubMed ID: 2670379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antiparasitic drugs. Review of the useful drugs in the treatment of classic and emergent parasitic diseases].
    Pérez JL; Carranza C; Mateos F
    Rev Esp Quimioter; 2009 Jun; 22(2):93-105. PubMed ID: 19544101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Tetracyclines, sulfonamides, and metronidazole].
    Vicente D; Pérez-Trallero E
    Enferm Infecc Microbiol Clin; 2010 Feb; 28(2):122-30. PubMed ID: 20097452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antibiotics: present and future].
    Bérdy J
    Orv Hetil; 2013 Apr; 154(15):563-73. PubMed ID: 23567874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiparasitic stewardship: a call to action.
    Becker SL; Schneitler S
    Future Microbiol; 2024 Jan; 19():5-8. PubMed ID: 38348569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimicrobial Activity of Chitosan Oligosaccharides with Special Attention to Antiparasitic Potential.
    Silva NSD; Araújo NK; Daniele-Silva A; Oliveira JWF; Medeiros JM; Araújo RM; Ferreira LS; Rocha HAO; Silva-Junior AA; Silva MS; Fernandes-Pedrosa MF
    Mar Drugs; 2021 Feb; 19(2):. PubMed ID: 33673266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunomodulatory Effects of Antimicrobial Drugs.
    Ruh C; Banjade R; Mandadi S; Marr C; Sumon Z; Crane JK
    Immunol Invest; 2017 Nov; 46(8):847-863. PubMed ID: 29058544
    [No Abstract]   [Full Text] [Related]  

  • 34. New Data on Molecular Targets of Tamoxifen Besides Estrogen Receptors, Their Clinical Significancy.
    Bogush TA; Polezhaev BB; Dudko EA; Bogush EA; Kirsanov VY; Polotsky BE; Tjuljandin SA; Davydov MI
    Antibiot Khimioter; 2016 Aug; 61():41-49. PubMed ID: 29874452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Essential veterinary education on the development of antimicrobial and antiparasitic resistance: consequences for animal health and food safety and the need for vigilance.
    Fanning S; Whyte P; O'Mahony M
    Rev Sci Tech; 2009 Aug; 28(2):575-82. PubMed ID: 20128466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adverse drug interactions in dental practice: interactions involving antibiotics. Part II of a series.
    Hersh EV
    J Am Dent Assoc; 1999 Feb; 130(2):236-51. PubMed ID: 10036847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A review of biological and pharmacological activities of Baccharis trimera.
    Silveira Rabelo AC; Caldeira Costa D
    Chem Biol Interact; 2018 Dec; 296():65-75. PubMed ID: 30240600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Infectiology and tropical medicine 2007].
    Löbermann M; Reisinger EC
    Dtsch Med Wochenschr; 2007 Jun; 132(25-26):1399-403. PubMed ID: 17570089
    [No Abstract]   [Full Text] [Related]  

  • 39. Current and future antifungal therapy: new targets for antifungal therapy.
    Andriole VT
    Int J Antimicrob Agents; 2000 Nov; 16(3):317-21. PubMed ID: 11091055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibacterial and antifungal activity of Erigeron breviscapus.
    Liu H; Yang XL; Ding JY; Feng YD; Xu HB
    Fitoterapia; 2003 Jun; 74(4):387-9. PubMed ID: 12781812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.